Sentinel lymph node biopsy (SLNB) for management of localized primary melanoma continues to have its critics, but Alistair Cochran, M.D., says that current data supports the procedure as a standard approach for staging patients with clinically localized, intermediate-thickness melanoma.
Ilya Petrou, M.D.
A tangential biopsy performed on melanonychia may often be the superior biopsy technique in exacting an accurate diagnosis of suspect lesions, according to Nilton Di Chiacchio, M.D., department of dermatology, Hospital of Public Service, Sao Paulo.
A new laser approach is proving highly effective in the treatment of onychomycosis, offering patients a new therapeutic option for this sometimes difficult-to-treat condition, said Jill S. Waibel, M.D., at the 2012 meeting of the American Society for Laser Medicine and Surgery.
The results of the first Multicenter Selective Lymphadenectomy Trial (MSLT-1) seem to indicate that survival in patients with intermediate thickness melanoma and metastatic disease in the regional nodes can be improved if early lymph node dissection is performed when a positive sentinel node is identified.
Leg hairs can be a convenient and natural-looking donor source for hair transplantation when restoring a thinning hairline. This approach offers an aesthetic solution for select patients with male pattern baldness, according to one hair transplant specialist.
A facial rejuvenation device that delivers fractional bipolar radiofrequency (RF) energy via microneedling directly into the dermis tightens skin and achieves measurable lifting and volume increase the likes of which have never been seen by any other devices on the market, said Lori Brightman, M.D., at the 2012 meeting of the American Society for Laser Medicine and Surgery.
Differentiating benign nail pigmentations such as melanonychia from either nail or nail matrix melanoma is especially difficult in children because pediatric lesions present differently than they do in adults, according to Antonella Tosti, M.D., professor of the department of dermatology and cutaneous surgery, University of Miami Miller School of Medicine.
Interferon and the recently Food and Drug Administration-approved pegylated interferon remain relevant adjuvant therapies for patients with lymph node-positive melanoma, even in light of advances with CTLA4 blockade and BRAF-targeted therapies for late-stage disease, says Vernon K. Sondak, M.D., chairman, department of cutaneous oncology, Moffitt Cancer Center, Tampa, Fla.
A novel genetic testing technique allows for patients who experience hair loss of any severity to know whether their condition is likely due to androgenetic alopecia.
An Er:YAG laser equipped with tiny, straight and curved micron tips allows physicians to perform ablative treatments of very small and typically hard-to-reach cutaneous lesions more quickly and easily compared to traditional straight tips.